Video

When Does The RA "Window of Opportunity" Actually Open?

(VIDEO) Researchers in Norway used data from an observational study of patients with swollen joints to see how many with early signs of rheumatoid arthritis recovered without any treatment at all, and how quickly.

How large is the window of opportunity for early DMARD treatment of early rheumatoid arthritis (RA)? And if you catch the symptoms quickly enough, what are the odds that you will initiate treatment for someone who would not have developed full-blown RA at all?

Researchers in Norway used data from a multicenter observational study of patients with swollen joints to see how many patients who showed early signs of RA actually recovered without any DMARD whatever, and how quickly.

"We found that when the duration of joint swelling was less than six weeks, 24% of the patients experienced resolving arthritis," says rheumatologist Ellen Sauar Norli MD in this video.

The study also showed a very strong correlation between the duration of joint swelling and outcome, according to number of classification criteria points for RA. The study provides specific hallmarks for avoiding overtreatment due to over-enthusiastic application of the mandate to detect and treat RA as early as possible.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.